Cytokine Profiles of Patients with Psoriasis Vulgaris who Experienced Acute Respiratory Infection with COVID-19

1 Menter A, Cordoro KM, Davis DM, Kroshinsky D, Paller AS, Armstrong AW, et al. Joint American academy of dermatology-national psoriasis foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82(1):161-201. Erratum in: J Am Acad Dermatol. 2020;82(3):574. https://doi.org/10.1016/j.jaad.2019.08.049. PMid:31703821 Search in Google Scholar

2 Turchin I, Bourcier M. The role of interleukins in the pathogenesis of dermatological immune-mediated diseases. Adv Ther. 2022;39(10):4474-508. https://doi.org/10.1007/s12325-022-02241-y PMid:35997892 Search in Google Scholar

3 Griffiths CE, Armstrong AW, Gudjonsson JE, Barker JN. Psoriasis. Lancet. 2021;397(10281):1301-15. https://doi.org/10.1016/S0140-6736(20)32549-6. PMid:33812489 Search in Google Scholar

4 Shah P, Zampella JG. Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic. J Am Acad Dermatol. 2020;82(6):e203-4. https://doi.org/10.1016/j.jaad.2020.03.056 PMid:32244021 Search in Google Scholar

5 Su CM, Wang L, Yoo D. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2. Sci Rep. 2021;11(1):13464. https://doi.org/10.1038/s41598-021-92941-2 PMid:34188167 Search in Google Scholar

6 Ozaras R, Berk A, Ucar DH, Duman H, Kaya F, Mutlu H. Covid-19 and exacerbation of psoriasis. Dermatol Ther. 2020;33(4):e13632. https://doi.org/10.1111/dth.13632 PMid:32436303 Search in Google Scholar

7 Kašnar AM, Jurić K, Franić A, Čeović R. Current knowledge on psoriasis during the covid-19 pandemic. Acta Dermatovenerol Croat. 2022;30(2):99-105. PMid:36254542 Search in Google Scholar

8 Bardazzi F, Loi C, Sacchelli L, Di Altobrando A. Biologic therapy for psoriasis during the covid-19 outbreak is not a choice. J Dermatolog Treat. 2020;31(4):320-1. https://doi.org/10.1080/09546634.2020.1749545 PMid:32248724. Search in Google Scholar

9 Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits. Dermatol Ther. 2020;33(4):e13490. https://doi.org/10.1111/dth.13490 PMid:32358864 Search in Google Scholar

10 Di Lernia V, Goldust M, FeLiciani C. Covid-19 infection in psoriasis patients treated with cyclosporin. Dermatol Ther. 2020;33(4):e13739. https://doi.org/10.1111/dth.13739 PMid:32478942 Search in Google Scholar

11 Megna M, Ruggiero A, Marasca C, Fabbrocini G. Biologics for psoriasis patients in the COVID-19 era: More evidence, Less fears. J Dermatolog Treat. 2020;31(4):328-9. https://doi.org/10.1080/09546634.2020.1757605 PMid:32301363 Search in Google Scholar

12 Gisondi P, Facheris P, Dapavo P, Piaserico S, Conti A, Naldi L, et al. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: The Northern Italy experience. Br J Dermatol. 2020;183(2):373-4. https://doi.org/10.1111/bjd.19158 PMid: 32343839 Search in Google Scholar

13 Carugno A, Gambini DM, Raponi F, Vezzoli P, Locatehi AG, Di Mercurio M, et al. COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy. J Am Acad Dermatol. 2020;83(1):292-4. https://doi.org/10.1016/].jaad.2020.04.165 PMid: 32387660 Search in Google Scholar

14 Kopcha VS. Osoblyvosti imunozalezhnykh proiaviv pry COVID-19 [Features of immune-dependent manifestations with COVID-19]. Infect Dis. 2021;2(104):4-16. https://doi.org/10.11603/1681-2727.2021.2.12159 Search in Google Scholar

15 Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo. Nat Med. 2000;6(5):583-8. Erratum in: Nat Med. 2010;16(11):1341. https://doi.org/10.1038/75068 PMid:10802717 Search in Google Scholar

16 Christophers E, Metzler G, Röcken M. Bimodal immune activation in psoriasis. Br J Dermatol. 2014;170(1):59-65. https://doi.org/10.1111/bjd.12631 PMid:24117368 Search in Google Scholar

17 Patrick MT, Zhang H, Wasikowski R, Prens EP, Weidinger S, Gudjonsson JE, et al. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies. J Allergy Clin Immunol. 2021;147(3):857-69.e7. https://doi.org/10.1016/j.jaci.2021.01.006 PMid:33485957 Search in Google Scholar